CANImmunize
Kumanan Wilson has an extensive work experience that spans over several prestigious organizations and roles. Kumanan is currently serving as a Scholar at the O'Neill Institute for National and Global Health Law since 2023. Prior to this, they held the position of Chief Executive Officer/Chief Scientific Officer at the Bruyère Research Institute starting from 2022.
Kumanan has also worked at Bruyère as the Vice President Research & Academic, where they played a significant role in digital health. Before joining Bruyère, Kumanan served as the Chief Scientific Officer and later became the Chief Executive Officer at CANImmunize from 2019 to 2022.
In addition to their corporate positions, Kumanan is involved in academic institutions and has made valuable contributions. Kumanan is currently holding the position of Faculty of Medicine Clinical Research Chair in Digital Health Innovation at the University of Ottawa since 2020.
Other notable roles include being a Professor of Medicine at the University of Ottawa since 2008, an Internal Medicine Physician and a Research Chair in Public Health Innovation at The Ottawa Hospital from 2008 to 2018, a Senior Scientist and a Canada Research Chair in Public Health Policy at the Ottawa Hospital Research Institute from 2008 to 2013.
Kumanan started their career at the University of Toronto and University Health Network as an Assistant/Associate Professor of Medicine and an Internal Medicine Physician, respectively, from 2001 to 2008. Kumanan also served as a Clinical Scholar/Internal Medicine Physician at the Ottawa Hospital, University of Ottawa from 1998 to 2001.
Kumanan Wilson completed their education history as follows:
- From 1997 to 1998, they pursued a Master of Science (MSc) degree in Clinical Epidemiology and Biostatistics from McMaster University.
- Prior to that, they attained a FRCP(C) degree in Internal Medicine from Western University from 1993 to 1997.
- In 1989, they earned a Doctor of Medicine (MD) degree from Western University.
- Lastly, from 1986 to 1989, they studied and received a Bachelor of Science (BSc) degree with a focus on Biology, General, from the University of New Brunswick.
This person is not in any teams
CANImmunize
CANImmunize is an Ottawa-based technology company specializing in immunization software. It developed the CANImmunize app, a pan-Canadian digital immunization tracking system that helps Canadians keep track of their vaccinations with a mobile app and web portal. The team also offers digital solutions such as Shield and ClinicFlow to businesses, health care organizations and governments for vaccinations and tracking for the COVID-19 vaccine rollout and other immunization needs. See how CANImmunize Shield can help organizations: https://www.canimmunize.ca/en/solutions/canimmunizeshield CANImmunize Shield is a digital tool to help employers know who is vaccinated, actively track and report employee vaccination rates, and protect unvaccinated employees, customers and the community. Our solution uses real-time verification of employee records using our smart vaccination status logic, rapid implementation to get your business back in the workplace as soon as possible, and will soon have QR code reading capabilities. We also provide human verification to validate vaccination records and medical or religious exemptions to ensure your employees are safe. Shield is a secured platform for employers to automate, manage, and verify vaccination proofs, boosters, rapid testing and daily screening logs for employees, contractors, and visitors. Shield Benefits: Real-time verification of records using our smart vaccination status. Rapid implementation - Have your employees uploading vaccinations in just days Precision immunity features and scientific rigour of our solution (including smart statuses and the integration of 3rd dose algorithms) Our experience with verification services; with embedding of QR code reading into the solution coming in 2022. Send discreet notifications to employees who have yet to upload their next dose, or require an additional dose